Kara Bickham

3.1k total citations · 1 hit paper
38 papers, 2.4k citations indexed

About

Kara Bickham is a scholar working on Epidemiology, Immunology and Oncology. According to data from OpenAlex, Kara Bickham has authored 38 papers receiving a total of 2.4k indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Epidemiology, 18 papers in Immunology and 8 papers in Oncology. Recurrent topics in Kara Bickham's work include Pneumonia and Respiratory Infections (16 papers), Immune Cell Function and Interaction (13 papers) and Respiratory viral infections research (11 papers). Kara Bickham is often cited by papers focused on Pneumonia and Respiratory Infections (16 papers), Immune Cell Function and Interaction (13 papers) and Respiratory viral infections research (11 papers). Kara Bickham collaborates with scholars based in United States, Israel and Australia. Kara Bickham's co-authors include Donna L. Färber, Joseph J.C. Thome, Damian Turner, Tomoaki Kato, Harvey Lerner, Masaru Kubota, Christian Münz, Ming L. Tsang, Ralph M. Steinman and Jean‐François Fonteneau and has published in prestigious journals such as Journal of Clinical Investigation, Nature Medicine and The Journal of Experimental Medicine.

In The Last Decade

Kara Bickham

36 papers receiving 2.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Distribution and Compartmentalization of Human Circulating and Tissue-Resident Memory T Cell Subsets

2012 624 citations Taheri Sathaliyawala, Masaru Kubota et al. Immunity profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Kara Bickham United States	16	1.7k	695	644	219	187	38	2.4k
Nicolas Dulphy France	31	2.2k 1.3×	558 0.8×	545 0.8×	264 1.2×	228 1.2×	69	2.9k
SangKon Oh United States	18	1.9k 1.1×	393 0.6×	337 0.5×	247 1.1×	210 1.1×	26	2.4k
Mathilde Dusséaux France	13	1.9k 1.1×	530 0.8×	280 0.4×	213 1.0×	189 1.0×	15	2.3k
Grazia Galli Italy	26	2.0k 1.2×	801 1.2×	771 1.2×	381 1.7×	319 1.7×	41	3.0k
Georg Stary Austria	27	1.4k 0.9×	464 0.7×	356 0.6×	394 1.8×	186 1.0×	79	2.5k
Katharina Grabmeier‐Pfistershammer Austria	29	1.3k 0.8×	715 1.0×	897 1.4×	333 1.5×	399 2.1×	86	2.6k
Emmanuel Treiner France	14	3.8k 2.3×	737 1.1×	575 0.9×	275 1.3×	209 1.1×	33	4.1k
Virginie Prémel France	12	2.4k 1.4×	571 0.8×	304 0.5×	208 0.9×	178 1.0×	13	2.6k
Rangsima Reantragoon Thailand	14	2.4k 1.4×	599 0.9×	335 0.5×	372 1.7×	196 1.0×	34	2.9k
Fran Hakim United States	16	1.0k 0.6×	673 1.0×	311 0.5×	213 1.0×	127 0.7×	34	2.0k

Countries citing papers authored by Kara Bickham

Since Specialization

Citations

This map shows the geographic impact of Kara Bickham's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kara Bickham with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kara Bickham more than expected).

Fields of papers citing papers by Kara Bickham

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kara Bickham. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kara Bickham. The network helps show where Kara Bickham may publish in the future.

Co-authorship network of co-authors of Kara Bickham

This figure shows the co-authorship network connecting the top 25 collaborators of Kara Bickham. A scholar is included among the top collaborators of Kara Bickham based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kara Bickham. Kara Bickham is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Anderson, Annaliesa S., et al.. (2026). Immunogenicity and safety of 20-valent pneumococcal conjugate vaccine in pneumococcal vaccine–naive adults ≥18 years of age in India: A phase 3 single-arm trial. Human Vaccines & Immunotherapeutics. 22(1). 2605847–2605847.

Martinón‐Torres, Federico, James Trammel, Yahong Peng, et al.. (2025). A phase 3 study of 20-valent pneumococcal conjugate vaccine in healthy toddlers previously vaccinated in infancy with 13-valent pneumococcal conjugate vaccine. Vaccine. 53. 126931–126931.

Smith, William B., Richard Chawana, Natalie C. Silmon de Monerri, et al.. (2025). A Phase 2b Trial Evaluating the Safety, Tolerability, and Immunogenicity of a 6-Valent Group B Streptococcus Vaccine Administered Concomitantly With Tetanus, Diphtheria, and Acellular Pertussis Vaccine in Healthy Nonpregnant Female Individuals. The Journal of Infectious Diseases. 231(6). e1065–e1074. 2 indexed citations

Martinón‐Torres, Federico, Jacek Wysocki, Leszek Szenborn, et al.. (2023). A Phase III, multicenter, randomized, double-blind, active comparator-controlled study to evaluate the safety, tolerability, and immunogenicity of V114 compared with PCV13 in healthy infants (PNEU-PED-EU-1). Vaccine. 41(21). 3387–3398. 15 indexed citations

Benfield, Thomas, Piero Valentini, Ron Dagan, et al.. (2023). Safety, tolerability, and immunogenicity of V114 pneumococcal vaccine compared with PCV13 in a 2+1 regimen in healthy infants: A phase III study (PNEU-PED-EU-2). Vaccine. 41(15). 2456–2465. 15 indexed citations

Lupinacci, Robert, Richard Rupp, Orasri Wittawatmongkol, et al.. (2023). A phase 3, multicenter, randomized, double-blind, active-comparator-controlled study to evaluate the safety, tolerability, and immunogenicity of a 4-dose regimen of V114, a 15-valent pneumococcal conjugate vaccine, in healthy infants (PNEU-PED). Vaccine. 41(5). 1142–1152. 26 indexed citations

Wilck, Marissa B., Shaun Barnabas, Kulkanya Chokephaibulkit, et al.. (2023). A phase 3 study of safety and immunogenicity of V114, a 15-valent pneumococcal conjugate vaccine, followed by 23-valent pneumococcal polysaccharide vaccine, in children with HIV. AIDS. 37(8). 1227–1237. 2 indexed citations

Quinn, Charles T., Richard T. Wiedmann, Daniel Jarovsky, et al.. (2022). Safety and immunogenicity of V114, a 15-valent pneumococcal conjugate vaccine, in children with SCD: a V114-023 (PNEU-SICKLE) study. Blood Advances. 7(3). 414–421. 6 indexed citations

Sieper, Joachim, Kara Bickham, Anish Mehta, et al.. (2016). A randomized, clinical trial to assess the relative efficacy and tolerability of two doses of etoricoxib versus naproxen in patients with ankylosing spondylitis. BMC Musculoskeletal Disorders. 17(1). 426–426. 11 indexed citations

10.

Bickham, Kara, Alan Kivitz, Anish Mehta, et al.. (2016). Evaluation of two doses of etoricoxib, a COX-2 selective non-steroidal anti-inflammatory drug (NSAID), in the treatment of Rheumatoid Arthritis in a double-blind, randomized controlled trial. BMC Musculoskeletal Disorders. 17(1). 331–331. 23 indexed citations

11.

Connors, Thomas J., Thyyar M. Ravindranath, Kara Bickham, et al.. (2015). Airway CD8+ T Cells Are Associated with Lung Injury during Infant Viral Respiratory Tract Infection. American Journal of Respiratory Cell and Molecular Biology. 54(6). 822–830. 48 indexed citations

12.

Turner, Damian, Kara Bickham, Joseph J.C. Thome, et al.. (2013). Lung niches for the generation and maintenance of tissue-resident memory T cells. Mucosal Immunology. 7(3). 501–510. 317 indexed citations

13.

Shimizu, Kanako, Takuya Mizuno, Jun Shinga, et al.. (2012). Vaccination with Antigen-Transfected, NKT Cell Ligand–Loaded, Human Cells Elicits Robust In Situ Immune Responses by Dendritic Cells. Cancer Research. 73(1). 62–73. 32 indexed citations

14.

Sathaliyawala, Taheri, Masaru Kubota, Naomi Yudanin, et al.. (2012). Distribution and Compartmentalization of Human Circulating and Tissue-Resident Memory T Cell Subsets. Immunity. 38(1). 187–197. 624 indexed citations breakdown →

15.

Shimizu, Kanako, Michihiro Hidaka, Kara Bickham, et al.. (2010). Human leukemic cells loaded with α-galactosylceramide (α-GalCer) activate murine NKT cells in situ. International Journal of Hematology. 92(1). 152–160. 6 indexed citations

16.

Bickham, Kara & Christian Münz. (2003). Contrasting Roles of Dendritic Cells and B Cells in the Immune Control of Epstein-Barr Virus. Current topics in microbiology and immunology. 276. 55–76. 6 indexed citations

17.

Lee, Andrew W., Tuan Truong, Kara Bickham, et al.. (2002). A clinical grade cocktail of cytokines and PGE2 results in uniform maturation of human monocyte-derived dendritic cells: implications for immunotherapy. Vaccine. 20. A8–A22. 173 indexed citations

18.

Bickham, Kara, Christian Münz, Ming L. Tsang, et al.. (2001). EBNA1-specific CD4+ T cells in healthy carriers of Epstein-Barr virus are primarily Th1 in function. Journal of Clinical Investigation. 107(1). 121–130. 98 indexed citations

19.

Larsson, Marie, Jean‐François Fonteneau, Selin Somersan, et al.. (2001). Efficiency of cross presentation of vaccinia virus-derived antigens by human dendritic cells. European Journal of Immunology. 31(12). 3432–3442. 83 indexed citations

20.

Subklewe, Marion, Ann Chahroudi, Kara Bickham, et al.. (1999). Presentation of Epstein-Barr virus latency antigens to CD8+, interferon-γ-secreting, T lymphocytes. European Journal of Immunology. 29(12). 3995–4001. 41 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact